• Join over 1.2 million students every month
  • Accelerate your learning by 29%
  • Unlimited access from just £6.99 per month

The Use of Recombinant DNA Technology Can Only Benefit Humans

Extracts from this document...

Introduction

The Use of Recombinant DNA Technology Can Only Benefit Humans I agree that recombinant DNA benefits humans only to a certain extent though. During the late 1960s and early 1970s a series of independent discoveries made in rapid succession yielded a new technology whereby humans have the capability to manipulate and direct the very evolution of life itself. This is accomplished through the process of gene splicing (Recombinant DNA). There are four essential elements of the process: a method of breaking and joining DNA molecules from different sources, a gene carrier that can replicate both itself and the foreign DNA, a means of introducing the foreign DNA into a functional bacteria cell, and a method of selecting from a large population the cells which carry the foreign DNA. Using procedures like recombinant DNA, many human genes have been cloned in E. coli or in yeast. ...read more.

Middle

People with failing kidneys can be kept alive by dialysis. But dialysis only cleanses the blood of wastes. Without a source of EPO, these patients suffer from anaemia. Now, thanks to recombinant DNA technology, recombinant human EPO is available to treat these patients, for treating anaemia, tissue plasminogen activator (TPA) for dissolving blood clots, angiostatin and endostatin for trials as anti-cancer drugs and parathyroid hormone. This shows that the use of recombinant DNA technology has benefited humans a lot over the past few years. A large Indiana-based pharmaceutical company developed a process for the production of human-type insulin through recombinant DNA technology. This insulin type, unlike that previously used, is biologically active and offers a great benefit to the diabetic. Many other biologists are also stepping up their production procedures for the manufacturing of products derived from gene splicing technology. ...read more.

Conclusion

But on the other hand it also benefits animals, not only humans. Livestock vaccines against diseases that attack the animals are also being produced, and they may be genetically engineering animals with less fat and more protein which better serve our nutritional needs. Recombinant DNA technology can be used to alter bacteria or small animals such as beetles or worms, so they destroy certain pests such as snails and slugs. But there are disadvantages of using this type o technology. By introducing a new predator into the ecosystem we deliberately alter its balance. Such an action may turn quiet harmful. The danger of this is if any particular organism does cause harmful knock on effects there will be problems removing it from the environment. This shows that the use of recombinant DNA technology does not ONLY benefit humans but benefits the whole environment and all the animals too. ...read more.

The above preview is unformatted text

This student written piece of work is one of many that can be found in our AS and A Level Genetics, Evolution & Biodiversity section.

Found what you're looking for?

  • Start learning 29% faster today
  • 150,000+ documents available
  • Just £6.99 a month

Not the one? Search for your essay title...
  • Join over 1.2 million students every month
  • Accelerate your learning by 29%
  • Unlimited access from just £6.99 per month

See related essaysSee related essays

Related AS and A Level Genetics, Evolution & Biodiversity essays

  1. Recombinant DNA, genetically engineered DNA prepared in vitro by cutting up DNA molecules and ...

    In practice, genes to be inserted into bacteria are first recombined into a plasmid, which replicates and travels independently from its bacterial host. The modified plasmid is then inserted into another bacterium. At the time that these methods became available, it was not known whether DNA could be replicated and expressed in a foreign organism.

  2. HSC maintaining a balance notes

    A group of three bases (codon) codes for a specific amino acid. Certain codes start and stop the chain formation. tRNA has an anticodon (non-amino acid forming) on one end and an amino acid on other. A polypeptide is formed as each amino acid is added from tRNA to a chain following the sequence on mRNA.

  1. Oncogenes are genes that cause cancer.

    Most of these cellular relatives of viral oncogenes obey the principles first deduced for c-src. They have the structural organization of cellular genes rather than of viral genes; they seem to have survived long periods of evolution, and they are active in normal cells.

  2. Chromosomes and DNA

    Cystic fibrosis Cystic fibrosis is caused by a recessive allele that controls the way mucus is formed. Mucus produced by people with cystic fibrosis is abnormally thick and sticky. As a result they have congested lungs and are more likely to get respiratory infections.

  1. Defense in the blood

    is a paradox for the typical argument. On the one hand, structural and sequence evidence for gene duplication and domain swapping in the clotting cascade is very clear. So clear, in fact, that cascade proteins are used as textbook examples of those processes (Li 1997).

  2. The use of recombinant gene technology can only benefit society

    Crops could be more resistance to pests 3. Enhance resistance to bacterial, fungal or viral diseases 4. Improve resistance to herbicides, so that crop plants are unaffected by herbicides used to control weeds 5. Enable plants to resist cold or drought 6.

  1. Research the use of recombinant DNA in the production of human insulin and two ...

    In the case of insulin, the gene needed is from a human chromosome from a pancreatic cell. The second step is to isolate that gene; there are two methods of doing this: - The first method involves cutting the gene from the rest of the DNA using restriction endonuclease enzymes; the required gene is located using electrophoresis.

  2. The Use of Recombinant DNA Technology Can Only Benefit Humans - "Recombinant DNA is ...

    Indeed scientific professionals admit that there is a definite bias towards use for human benefit "because the financial markets really understand that if you make a drug against cancer or AIDS, it will have a proven market." [S. Burrill, biotechnology specialist for Ernst & Young].

  • Over 160,000 pieces
    of student written work
  • Annotated by
    experienced teachers
  • Ideas and feedback to
    improve your own work